Legal Representation
Attorney
Tara Reedy Sliva
Application History
24 eventsDate | Code | Type | Description |
---|---|---|---|
Apr 22, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Feb 25, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Feb 25, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
Feb 19, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Jan 31, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jan 30, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Jan 30, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jan 30, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Oct 30, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
Oct 30, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Oct 30, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
Oct 22, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Oct 22, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Oct 22, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jul 22, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
Jul 22, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
Jul 22, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Jul 22, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
Jul 22, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Jul 22, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
Jul 17, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
Nov 10, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Nov 9, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Oct 29, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
Biochemicals and organic chemicals used as enzyme substrates, enzyme inducers, namely, aminoglutethimides, carbamazepines, griseofulvins, and primidones, enzyme inactivators, or cultural medium additives for use in the field of microbiology and molecular biology for scientific purposes; biochemical and organic chemical reagents for clinical diagnostic laboratory use; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics; Chemical reagents for medical research use in the field of immunology
Class 005
Medicinal preparations, namely, photosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as culture media for cultures of microorganisms for medical use, namely, for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Organic chemical preparations for medical purposes, namely, immunomodulators with anti-inflammatory properties; Organic chemical preparations and enzymes for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA); Chemical reagents for medical laboratory analysis purposes, namely, for use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms
Additional Information
Design Mark
The mark consists of four stacked wavy lines in the colors of navy, orange, teal and blue. The wavy lines are intersected with lines forming four overlapping diamonds that are comprised of four smaller diamonds. The top quadrant of the diamonds is in navy for the top half and orange for the bottom half. The left and right quadrants of the diamonds are in orange for the top half and teal for the bottom half. The bottom quadrant of the diamonds is in teal for the top half and blue for the bottom half. The color white represents background and/or transparent areas and is not a feature of the mark.
Color Claim
The color(s) navy, orange, teal and blue is/are claimed as a feature of the mark.
Classification
International Classes
001
005